AlphaCore Capital »

Fate Therapeutics shares owned by AlphaCore Capital

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by AlphaCore Capital from 13F filings

Historical chart of AlphaCore Capital investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by AlphaCore Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by AlphaCore Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $13k 13k 0.98

More positions owned by AlphaCore Capital

Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Meta Platforms Cl A (META)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Schwab Strategic Tr Fundamental Us L (FNDX)
MPLX Com Unit Rep Ltd (MPLX)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Vanguard Index Fds Large Cap Etf (VV)
Schwab Strategic Tr Fundamental Intl (FNDF)
Apple (AAPL)
Ishares Tr Core Msci Total (IXUS)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation Call Option (MSFT)
Etf Ser Solutions Distillate Us (DSTL)
Wisdomtree Tr Intl Qulty Div (IQDG)

View all positions for AlphaCore Capital

Top funds holding Fate Therapeutics

Redmile Group
BlackRock
Vanguard Group
Wilshire Associates
Johnson & Johnson
Acadian Asset Management
Geode Capital Management
Renaissance Technologies
State Street Corporation
Vestal Point Capital
Dimensional Fund Advisors
Point72 Asset Management
Goldman Sachs Group
Tang Capital Management
AQR Capital Management

View all funds holding Fate Therapeutics